← Leaderboards
Sandra C Vigil-Cruz
University Of Kansas Lawrence
$410,533
Attributed
$410,533
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $155.9K · FY2005–07$200K$150K$100K$50K$0
'05
'06
'07
Funding mix
By agency
NIH$410,533 · 3
By mechanism
P20$410,533 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Kansas Lawrence
Same institution · by research overlap
- Gunda I. Georg$26,008,014
- Sunil Abraham David$6,046,203
- Qi-Zhuang Ye$3,627,989
- Diane L Persons$0
- Scott C Todd$2,000
Others in their field
Top investigators on “Drug Discovery /Isolation”
- Nicholas Mark Valiante · Novartis Vaccines And Diagnostics, Inc.$4,680,300
- David G Kingston · Virginia Polytechnic Inst And St Univ$4,392,799
- William H Gerwick · Oregon State University$3,733,787
- John C Reed · University Of Texas Md Anderson Can Ctr$3,652,024
- Jeffery W Kelly · Scripps Research Institute$3,466,562
- Kathryn Frances Sykes · Eliance Biotechnology, Inc.$3,423,850
Research focus
Drug Discovery /IsolationPeptidesNeoplasm /Cancer PharmacologyNeoplasm /Cancer ChemotherapyBinding (Molecular Function)BreastAnalogCell SurfaceBaseChemokine ReceptorChemotherapeutic AgentClassComputer Retrieval Of Information On Scientific Projects DatabaseCxcr4 GeneCellsDesignCxcr4 ReceptorsFundingFutureGrantGrowth InhibitorsGuanosine Triphosphate PhosphohydrolasesInhibitor/AntagonistBreast Neoplasms
Grant awards (4)
NOVEL PEPTIDE INHIBITORS OF BREAST TUMOR GROWTH$11,863
P20 · FY2007 · RR · contact PI
NOVEL PEPTIDE INHIBITORS OF BREAST TUMOR GROWTH$68,327
P20 · FY2006 · RR · contact PI
NOVEL PEPTIDE INHIBITORS OF BREAST TUMOR GROWTH$155,940
P20 · FY2005 · RR
NOVEL PEPTIDE INHIBITORS OF BREAST TUMOR GROWTH$174,403
P20 · FY2004 · RR